Tina Williams
Psychiatric/Mental Health · Decatur, GANPI 1871818526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 364 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$775
- Alkermes, Inc.$667
- Otsuka America Pharmaceutical, Inc.$638
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$470
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,90396%
- Education$2654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 75 | $1,124 |
| Johnson & Johnson | 39 | $1,116 |
| Neurocrine Biosciences, Inc. | 31 | $775 |
| Alkermes, Inc. | 31 | $667 |
| Otsuka America Pharmaceutical, Inc. | 30 | $638 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $470 |
| Axsome Therapeutics, Inc. | 12 | $324 |
| AbbVie | 34 | $322 |
| Lundbeck LLC | 16 | $281 |
| Tris Pharma Inc | 10 | $204 |
| Vanda Pharmaceuticals Inc. | 6 | $181 |
| E.r. Squibb & Sons, L.L.C. | 6 | $159 |
| Acadia Pharmaceuticals Inc | 7 | $134 |
| Supernus Pharmaceuticals, Inc. | 6 | $129 |
| Bausch Health US, LLC | 6 | $119 |
| Indivior Inc. | 5 | $101 |
| GSK | 6 | $98 |
| Collegium Pharmaceutical, Inc. | 3 | $66 |
| Ironshore Pharmaceuticals Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Avanir Pharmaceuticals, Inc. | 3 | $52 |
| Merck | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Tempus AI, Inc | 1 | $16 |
| Acessa Health Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
How this compares
$7,168 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 27 | $223,075 |
| Invega SustennaPaliperidone Palmitate | 43 | $98,600 |
| AristadaAripiprazole Lauroxil | 30 | $81,656 |
| Abilify MaintenaAripiprazole | 25 | $50,835 |
| LybalviOlanzapine/Samidorphan Malate | 23 | $35,319 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $16,954 |
| TrintellixVortioxetine Hydrobromide | 11 | $9,890 |
| Fluphenazine Hcl | 24 | $4,862 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 75 | $3,939 |
| Quetiapine Fumarate | 199 | $3,416 |
| Duloxetine Hcl | 47 | $3,278 |
| Buspirone Hcl | 95 | $2,742 |
| Paliperidone ErPaliperidone | 23 | $2,553 |
| Trazodone Hcl | 182 | $2,480 |
| Bupropion XlBupropion Hcl | 120 | $2,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza, Invega Sustenna | $1,116 | $321,67570 claims |
| Alkermes, Inc.Aristada, Lybalvi | $667 | $116,97653 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $638 | $50,83525 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $52 | $16,95412 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $58 | $9,89011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Decatur
- Jessica KettellDecatur$7K
- Dorcas MwangiDecatur$7K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.